Core Laboratories (CLB) News Today

StockNews.com upgraded shares of Core Laboratories from a "sell" rating to a "hold" rating in a research note on Friday.

Stifel Nicolaus boosted their target price on Core Laboratories from $18.00 to $22.00 and gave the company a "hold" rating in a research report on Friday.

Core Laboratories (NYSE:CLB - Get Free Report) announced its quarterly earnings results on Wednesday. The oil and gas company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.21 by $0.01. The company had revenue of $130.58 million during the quarter, compared to analyst estimates of $132.85 million. Core Laboratories had a return on equity of 15.71% and a net margin of 8.18%. The firm's revenue was up 2.1% on a year-over-year basis. During the same period in the prior year, the firm posted $0.23 earnings per share.

Core Laboratories (NYSE:CLB) Stock Price Up 9.4% Following Strong Earnings

Core Laboratories (NYSE:CLB) updated its third quarter earnings guidance. The company provided EPS guidance of $0.23-0.27 for the period, compared to the consensus estimate of $0.24. The company also issued revenue guidance of $131-137 millionillion, compared to the consensus estimate of $136.07 millionillion.

Core Laboratories (NYSE:CLB) Trading Down 3.6%

Shares of Core Laboratories Inc. (NYSE:CLB - Get Free Report) have been given a consensus recommendation of "Reduce" by the four brokerages that are covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating and two have given a hold rating to th

Core Laboratories Inc. (NYSE:CLB - Free Report) - Research analysts at Zacks Research reduced their Q2 2024 earnings estimates for Core Laboratories in a research note issued to investors on Tuesday, July 16th. Zacks Research analyst T. Saha now forecasts that the oil and gas company will earn $0

Core Laboratories Inc. (NYSE:CLB - Get Free Report) was the recipient of a large decrease in short interest in the month of June. As of June 30th, there was short interest totalling 6,590,000 shares, a decrease of 8.1% from the June 15th total of 7,170,000 shares. Currently, 14.2% of the company's stock are short sold. Based on an average daily volume of 408,300 shares, the short-interest ratio is currently 16.1 days.

Bank of America decreased their target price on shares of Core Laboratories from $16.00 to $15.00 and set an "underperform" rating on the stock in a research report on Monday.

Susquehanna Fundamental Investments LLC purchased a new stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 72,446 shares of the oil and gas company's stock, valued at approxim

StockNews.com downgraded shares of Core Laboratories from a "hold" rating to a "sell" rating in a report on Wednesday.

Van ECK Associates Corp increased its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 9.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 639,071 shares of the oil and gas company's stock aft

Congress Wealth Management LLC DE raised its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 40.8% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 183,282 shares of the oil and gas company's stock after buying an additional 53,090 sha

Core Laboratories Inc. (NYSE:CLB - Get Free Report) has been assigned a consensus rating of "Reduce" from the four ratings firms that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell recommendation and two have assigned a hold recommendation to th

Congress Asset Management Co. MA increased its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 17.6% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 1,606,745 shares of the oil and gas company's stock after acquiring

Fisher Asset Management LLC grew its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 21.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 754,407 shares of the oil and gas company's stock after pu

Confluence Investment Management LLC purchased a new position in Core Laboratories Inc. (NYSE:CLB - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 146,048 shares of the oil and gas company's stock, valued at approximately $2,

Congress Asset Management Co. MA raised its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 21.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,365,756 shares of the oil and ga

Gendell Jeffrey L lifted its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 35.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 162,093 shares of the oil and gas company's stock after purchasing an additiona

Core Laboratories Inc. (NYSE:CLB - Free Report) - Zacks Research reduced their Q2 2024 earnings per share (EPS) estimates for shares of Core Laboratories in a note issued to investors on Monday, June 10th. Zacks Research analyst T. Saha now anticipates that the oil and gas company will post earni

Core Laboratories Inc. (NYSE:CLB - Free Report) - Equities researchers at Zacks Research cut their Q3 2024 earnings estimates for Core Laboratories in a research note issued to investors on Monday, June 10th. Zacks Research analyst T. Saha now expects that the oil and gas company will earn $0.21

Shares of Core Laboratories Inc. (NYSE:CLB - Get Free Report) have been given a consensus recommendation of "Reduce" by the four analysts that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating and two have given a hold rating to the co

Core Laboratories Inc. (NYSE:CLB - Get Free Report) saw a large increase in short interest in April. As of April 30th, there was short interest totalling 6,610,000 shares, an increase of 10.7% from the April 15th total of 5,970,000 shares. Based on an average daily volume of 398,800 shares, the short-interest ratio is currently 16.6 days. Currently, 14.2% of the shares of the stock are sold short.

Partnership Wealth Management LLC bought a new position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 124,379 shares of the oil and gas company's stock, valued at approximately $2

Fisher Asset Management LLC lifted its stake in Core Laboratories Inc. (NYSE:CLB - Free Report) by 21.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 753,555 shares of the oil and gas company's stock after purchasing an additional 133,

Van ECK Associates Corp lowered its stake in Core Laboratories Inc. (NYSE:CLB - Free Report) by 17.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 586,432 shares of the oil and gas company's stock after selling 121,436 shares during the quarter. Va

Core Laboratories Inc. (NYSE:CLB - Get Free Report) was the recipient of a large decrease in short interest in April. As of April 15th, there was short interest totalling 5,970,000 shares, a decrease of 9.4% from the March 31st total of 6,590,000 shares. Approximately 12.9% of the shares of the company are short sold. Based on an average trading volume of 453,200 shares, the short-interest ratio is currently 13.2 days.

Stifel Nicolaus raised their price objective on Core Laboratories from $17.00 to $18.00 and gave the company a "hold" rating in a research note on Friday.

Core Laboratories Inc. (NYSE:CLB) announced a quarterly dividend on Wednesday, April 24th. Investors of record on Monday, May 6th will be paid a dividend of 0.01 per share by the oil and gas company on Tuesday, May 28th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.23%. The ex-dividend date is Friday, May 3rd.

Core Laboratories (NYSE:CLB) Shares Gap Up After Earnings Beat